StockNews.com Begins Coverage on Mannatech (NASDAQ:MTEX)

Equities researchers at StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a research note issued on Sunday. The firm set a “buy” rating on the stock.

Mannatech Stock Performance

NASDAQ:MTEX opened at $10.97 on Friday. Mannatech has a twelve month low of $6.75 and a twelve month high of $16.49. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44. The stock has a market cap of $20.68 million, a P/E ratio of -13.54 and a beta of 1.02. The business’s 50-day moving average price is $12.23 and its two-hundred day moving average price is $9.69.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.